Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' TYBRING G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 28 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hartter, S; Morita, S; Bodin, K; Ursing, C; Tybring, G; Bertilsson, L
      Determination of exogenous melatonin and its 6-hydroxy metabolite in humanplasma by liquid chromatography-mass spectrometry

      THERAPEUTIC DRUG MONITORING
    2. Yasar, U; Tybring, G; Hidestrand, M; Oscarson, M; Ingelman-Sundberg, M; Dahl, ML; Eliasson, E
      Role of CYP2C9 polymorphism in losartan oxidation

      DRUG METABOLISM AND DISPOSITION
    3. Yasui-Furukori, N; Hidestrand, M; Spina, E; Facciola, G; Scordo, MG; Tybring, G
      Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes

      DRUG METABOLISM AND DISPOSITION
    4. Facciola, G; Hidestrand, M; von Bahr, C; Tybring, G
      Cytochrome P-450 isoforms involved in melatonin metabolism in human liver microsomes

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    5. Laine, K; Tybring, G; Hartter, S; Andersson, K; Svensson, JO; Widen, J; Bertilsson, L
      Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    6. Hartter, S; Ursing, C; Morita, S; Tybring, G; von Bahr, C; Christensen, M; Rojdmark, S; Bertilsson, L
      Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: A pilot study

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. von Bahr, C; Ursing, C; Yasui, N; Tybring, G; Bertilsson, L; Rojdmark, S
      Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P-450 CYP1A2 and CYP2C19 hydroxylate melatonin

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    8. Sagar, M; Tybring, G; Dahl, ML; Bertilsson, L; Seensalu, R
      Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism

      GASTROENTEROLOGY
    9. Laine, K; Tybring, G; Bertilsson, L
      No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    10. Mihara, K; Svensson, USH; Tybring, G; Hai, TN; Bertilsson, L; Ashton, M
      Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    11. TYBRING G; NORDIN J; WIDEN J
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY FOR THE QUANTIFICATION OF NORTRIPTYLINE AND 10-HYDROXYNORTRIPTYLINE IN PLASMA

      Journal of chromatography B. Biomedical sciences and applications
    12. SAGAR M; SEENSALU R; TYBRING G; DAHL ML; BERTILSSON L
      CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION

      Scandinavian journal of gastroenterology
    13. OTANI K; TYBRING G; MIHARA K; YASUI N; KANEKO S; OHKUBO T; NAGASAKI T; SUGAWARA K
      CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS OF MIANSERIN AND TRAZODONE IN DEPRESSED-PATIENTS

      European Journal of Clinical Pharmacology
    14. SAGAR M; TYBRING G; DAHL ML; BERTILSSON L; SEENSALU R
      THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE

      Gastroenterology
    15. YUE QY; ZHONG ZH; TYBRING G; DALEN P; DAHL ML; BERTILSSON L; SJOQVIST F
      PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES

      Clinical pharmacology and therapeutics
    16. HERRLIN K; MASSELE AY; JANDE M; ALM C; TYBRING G; ABDI YA; WENNERHOLM A; JOHANSSON I; DAHL ML; BERTILSSON L; GUSTAFSSON LL
      BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE

      Clinical pharmacology and therapeutics
    17. YASUI N; TYBRING G; OTANI K; MIHARA K; SUZUKI A; SVENSSON JO; KANEKO S
      EFFECTS OF THIORIDAZINE, AN INHIBITOR OF CYP2D6, ON THE STEADY-STATE PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND ITS ACTIVE METABOLITE, DESMETHYLMIANSERIN, IN DEPRESSED JAPANESE PATIENTS

      Pharmacogenetics
    18. BERTILSSON L; TYBRING G; WIDEN J; CHANG M; TOMSON T
      CARBAMAZEPINE TREATMENT INDUCES THE CYP3A4 CATALYZED SULFOXIDATION OFOMEPRAZOLE, BUT HAS NO OR LESS EFFECT ON HYDROXYLATION VIA CYP2C19

      British journal of clinical pharmacology
    19. MIHARA K; OTANI K; TYBRING G; DAHL ML; BERTILSSON L; KANEKO S
      THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS

      Journal of clinical psychopharmacology
    20. SAGAR M; BERTILSSON L; DAHL ML; TYBRING G; SEENSALU R
      INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION

      Gastroenterology
    21. BOTTIGER Y; TYBRING G; GOTHARSON E; BERTILSSON L
      INHIBITION OF THE SULFOXIDATION OF OMEPRAZOLE BY KETOCONAZOLE IN POORAND EXTENSIVE METABOLIZERS OF S-MEPHENYTOIN

      Clinical pharmacology and therapeutics
    22. TYBRING G; BOTTIGER Y; WIDEN J; BERTILSSON L
      ENANTIOSELECTIVE HYDROXYLATION OF OMEPRAZOLE CATALYZED BY CYP2C19 IN SWEDISH WHITE SUBJECTS

      Clinical pharmacology and therapeutics
    23. BERTILSSON L; DAHL ML; TYBRING G
      PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS

      Acta psychiatrica Scandinavica
    24. ROH HK; DAHL ML; TYBRING G; YAMADA H; CHA YN; BERTILSSON L
      CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED BY OMEPRAZOLE IN A KOREAN POPULATION

      Pharmacogenetics
    25. CHANG M; DAHL ML; TYBRING G; GOTHARSON E; BERTILSSON L
      USE OF OMEPRAZOLE AS A PROBE DRUG FOR CYP2C19 PHENOTYPE IN SWEDISH CAUCASIANS - COMPARISON WITH S-MEPHENYTOIN HYDROXYLATION PHENOTYPE AND CYP2C19 GENOTYPE

      Pharmacogenetics
    26. CHANG M; TYBRING G; DAHL ML; GOTHARSON E; SAGAR M; SEENSALU R; BERTILSSON L
      INTERPHENOTYPE DIFFERENCES IN DISPOSITION AND EFFECT ON GASTRIN-LEVELS OF OMEPRAZOLE - SUITABILITY OF OMEPRAZOLE AS A PROBE FOR CYP2C19

      British journal of clinical pharmacology
    27. TYBRING G; OTANI K; KANEKO S; MIHARA K; FUKUSHIMA Y; BERTILSSON L
      ENANTIOSELECTIVE DETERMINATION OF MIANSERIN AND ITS DESMETHYL METABOLITE IN PLASMA DURING TREATMENT OF DEPRESSED JAPANESE PATIENTS

      Therapeutic drug monitoring
    28. DAHL ML; TYBRING G; ELWIN CE; ALM C; ANDREASSON K; GYLLENPALM M; BERTILSSON L
      STEREOSELECTIVE DISPOSITION OF MIANSERIN IS RELATED TO DEBRISOQUIN HYDROXYLATION POLYMORPHISM

      Clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 21:19:42